AZR-MD-001
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for AZR-MD-001, covering 2022-05-16 to 2024-09-27. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 3 Study to Evaluate AZR-MD-001 in Patients with Abnormal Meibomian Gland Function and Dry Eye Disease (DED) [Phase 3]